Company news
Cipher Pharmaceuticals Inc. news in 2023
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2023, newest first.
Cipher Pharmaceuticals Announces Change of Auditor
November 24, 2023
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
November 15, 2023
Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023
November 9, 2023
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call
October 27, 2023
Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid
October 12, 2023
Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer Bid
October 3, 2023
Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian Dollars
September 5, 2023
Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in Mexico
August 10, 2023
Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference Call
July 28, 2023
Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European Union
July 5, 2023
Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility
May 11, 2023
Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call
May 4, 2023
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
March 16, 2023
Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call
March 10, 2023
Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit Facility
March 1, 2023